India Coronavirus Dispatch: How the lockdown upended Adivasi communities

Young women are bearing the brunt of the pandemic, how researchers are getting by, and virus spike proteins imaged in their natural state-news relevant to India's fight against Covid-19

A woman passes the stone erected at the village crossing. | Photo: Ankur Paliwal
A woman passes the stone erected at the village crossing. | Photo: Ankur Paliwal
Bharath Manjesh New Delhi
4 min read Last Updated : Dec 21 2020 | 3:25 PM IST
India’s unplanned lockdown unleashed fresh hell for its Adivasis

The lockdown imposed in March took the general public by surprise and several sections of society were reeling from it for months. The Adivasis and other forest-dwelling communities, which at 104 million individuals make up 8.6% of the population, were particularly hard hit.

Since the Adivasi communities live in remote areas, information about the disease was not adequately available, to begin with. These communities who have been marginalised in terms of access to healthcare were badly hit as Covid-19 impacts people with compromised health conditions and low immunity. A complete lockdown, restricted entry to forests and closed markets are all factors that have increased their vulnerability as they depend on the forests for their livelihoods and several other purposes. The absence of government support worsens their position, the writer of the article says. 

Adivasi communities are also heavily dependent on agriculture. However, in the past decade, the number of agricultural labourers grew by 9%, while the number of Adivasi cultivators has contracted by 10%. This meant many found it hard to access either agricultural or non-agricultural livelihood options during the lockdown, the writer says. Read more here

Young women are bearing the brunt of pandemic disruption

The Covid-19 pandemic has likely upended millions of lives in India. However, women are bearing the brunt of the disruption and the repercussions could take a long time to reverse.

According to a recent study released by LinkedIn, based on internal data for India, women’s participation in the labour force actually rose by 7% between April and July. However, this applied only to a small demographic of women—the urban and the educated. This also applies only to jobs in the formal, white-collar, urban economy, which makes a fraction of the labour market, the writer of this article says.

For most Indian women, the situation is deeply worrying. Especially, young women in their early 20s. According to CMIE data, by the end of 2019, young women were starting to recover from the twin shocks of demonetization in 2016 and the introduction of GST in 2017. Their workforce participation rate which had climbed up to 14.3%, has shrunk that rate to 8.7% in the current recession, the writer says. Read more here

How researchers are getting by amid the pandemic

While research around Covid-19 has taken place at a rapid pace, non-coronavirus research meanwhile has suffered. 

Many researchers struggled to sustain their research programs with labs and offices shut. Their fieldwork and experiments were postponed. Many took the opportunity to catch up on writing grants and papers. Some came up with workarounds to keep the scientific juices flowing, the writer of the article says.

Here are a few slices of scientific life during the pandemic. Among them is a specialist keeping alive genetically important strains of fruit flies, and a paediatrician struggling to manage clinical trials for a rare genetic disease, the writer says. Read more here

Study points to benefits of indomethacin in Covid-19 care

A study conceived by Rajan Ravichandran, senior nephrologist, MIOT Hospital in Chennai, and executed along with R. Krishnakumar of the Department of Engineering Design at the Indian Institute of Technology-Madras has advanced the case to use indomethacin, a drug conventionally used in the treatment of rheumatoid arthritis for faster symptomatic relief and preventing progression of pneumonia in Covid-19 patients 

In a pre-print published recently in Medrxiv, the authors have called for indomethacin to replace paracetamol if there is no contraindication for its use, the writer of the article says citing the study.

Patients treated with indomethacin had a reduction in the number of days to become fever-free, and reduction in cough and muscle pain by half compared to paracetamol. There was no evidence of adverse reaction to indomethacin or deterioration of renal or liver function, the writer says citing the findings. Read more here

Spike proteins on coronaviruses imaged in their natural state

According to a study in the Quarterly Reviews of Biophysics Discovery, a team of researchers have developed a method, which combines cryogenic electron microscopy (cryo-EM) and computation, to produce quicker and more realistic snapshots of the protein “spikes" on coronaviruses. 

Coronaviruses including the one that causes Covid-19, get their name from the “corona” or crown shape created by the protein “spikes” on their surface. These spike proteins bind with human proteins to cause infection, the writer of the article says. See here

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :CoronavirusCoronavirus TestsCoronavirus Vaccine

Next Story